The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Cheng, Z.-X., Yin, W.-B., & Wang, Z. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3124 · Cited by 35
RetractedWu, Z., Han, Y., Li, Y., Li, X., Sun, T., Chen, G., Huang, Y., Zhou, Y., & Du, Z. (2015) · Oncology Reports · doi:10.3892/or.2015.4418 · Cited by 21
RetractedThe 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Parzych, K. R., & Klionsky, D. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5371 · Cited by 2,521
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Mechanisms and functions of DNA mismatch repair
Li, G.-M. (2008) · Cell Research · doi:10.1038/cr.2007.115 · Cited by 1,487
Krokan, H. E., & Bjoras, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012583 · Cited by 1,322
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Temozolomide resistance in glioblastoma multiforme
Lee, S. Y. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.04.007 · Cited by 1,163
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
The Double-Edged Sword of Autophagy Modulation in Cancer
White, E., & DiPaola, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5023 · Cited by 1,138
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Lathia, J. D., Gallagher, J., Heddleston, J. M., Wang, J., Eyler, C. E., MacSwords, J., Wu, Q., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.018 · Cited by 660
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
Han, S., Liu, Y., Cai, S. J., Qian, M., Ding, J., Larion, M., Gilbert, M. R., & Yang, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0814-x · Cited by 657
IDH1 and IDH2 mutations in gliomas
Cohen, A. L., Holmen, S. L., & Colman, H. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0345-4 · Cited by 629
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
Munoz, J. L., Bliss, S. A., Greco, S. J., Ramkissoon, S. H., Ligon, K. L., & Rameshwar, P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.60 · Cited by 520
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Kim, H., & D'Andrea, A. D. (2012) · Genes & Development · doi:10.1101/gad.195248.112 · Cited by 508
Overview of macroautophagy regulation in mammalian cells
Mehrpour, M., Esclatine, A., Beau, I., & Codogno, P. (2010) · Cell Research · doi:10.1038/cr.2010.82 · Cited by 490
DNA double strand break repair via non-homologous end-joining.
Davis, A. J., & Chen, D. J. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.04.02 · Cited by 456
IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
Ogden, A. T., Waziri, A. E., Lochhead, R. A., Fusco, D., Lopez, K., Ellis, J. A., Kang, J., Assanah, M., McKhann, G. M., Sisti, M. B., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316019.28421.95 · Cited by 408
ATR couples FANCD2 monoubiquitination to the DNA-damage response
Andreassen, P. R., D'Andrea, A. D., & Taniguchi, T. (2004) · Genes & Development · doi:10.1101/gad.1196104 · Cited by 408
DNA glycosylases: In DNA repair and beyond
Jacobs, A. L., & Schär, P. (2012) · Chromosoma · doi:10.1007/s00412-011-0347-4 · Cited by 407
Yip, S., Miao, J., Cahill, D. P., Iafrate, A. J., Aldape, K., Nutt, C. L., & Louis, D. N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3012 · Cited by 400
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Kitange, G. J., Carlson, B. L., Schroeder, M. A., Grogan, P. T., Lamont, J. D., Decker, P. A., Wu, W., James, C. D., & Sarkaria, J. N. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-090 · Cited by 390
Autophagy: An Essential Degradation Program for Cellular Homeostasis and Life
Chun, Y., & Kim, J. (2018) · Cells · doi:10.3390/cells7120278 · Cited by 380
Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
Read, T.-A., Fogarty, M. P., Markant, S. L., McLendon, R. E., Wei, Z., Ellison, D. W., Febbo, P. G., & Wechsler-Reya, R. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.016 · Cited by 370
Auffinger, B., Tobias, A. L., Han, Y., Lee, G., Guo, D., Dey, M., Lesniak, M. S., & Ahmed, A. U. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.31 · Cited by 349
Targeting cellular pathways in glioblastoma multiforme
Pearson, J. R. D., & Regad, T. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.40 · Cited by 344
Shi, L., Chen, J., Yang, J., Pan, T., Zhang, S., & Wang, Z. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.009 · Cited by 343
Mansouri, A., Hachem, L. D., Mansouri, S., Nassiri, F., Laperriere, N. J., Xia, D., Lindeman, N. I., Wen, P. Y., Chakravarti, A., Mehta, M. P., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noy132 · Cited by 340
Agarwala, S. S., & Kirkwood, J. M. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2-144 · Cited by 330
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
JIAPAER, S., FURUTA, T., TANAKA, S., KITABAYASHI, T., & NAKADA, M. (2018) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2018-0141 · Cited by 324
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Taylor, O. G., Brzozowski, J. S., & Skelding, K. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00963 · Cited by 322
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández-Tiedra, S., Salazar, M., García-Taboada, E., Barcia, J., Guzmán, M., & Velasco, G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0688 · Cited by 301
DNA Damage Induced by Alkylating Agents and Repair Pathways
Kondo, N., Takahashi, A., Ono, K., & Ohnishi, T. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/543531 · Cited by 292
Hombach-Klonisch, S., Mehrpour, M., Shojaei, S., Harlos, C., Pitz, M., Hamai, A., Siemianowicz, K., Likus, W., Wiechec, E., Toyota, B. D., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.017 · Cited by 292
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Strobel, H., Baisch, T., Fitzel, R., Schilberg, K., Siegelin, M. D., Karpel-Massler, G., Debatin, K.-M., & Westhoff, M.-A. (2019) · Biomedicines · doi:10.3390/biomedicines7030069 · Cited by 279
DNA double-strand break repair by homologous recombination
Dudáš, A., & Chovanec, M. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.07.001 · Cited by 271
Using the molecular classification of glioblastoma to inform personalized treatment
Olar, A., & Aldape, K. D. (2014) · The Journal of Pathology · doi:10.1002/path.4282 · Cited by 261
Buccarelli, M., Marconi, M., Pacioni, S., De Pascalis, I., D’Alessandris, Q. G., Martini, M., Ascione, B., Malorni, W., Larocca, L. M., Pallini, R., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0864-7 · Cited by 257
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Griguer, C. E., Oliva, C. R., Gobin, E., Marcorelles, P., Benos, D. J., Lancaster, J. R., & Gillespie, G. Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003655 · Cited by 247
Targeting autophagy-related protein kinases for potential therapeutic purpose
Xiang, H., Zhang, J., Lin, C., Zhang, L., Liu, B., & Ouyang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.003 · Cited by 246
Repair of DNA containing O 6 ‐alkylguanine
Pegg, A. E., & Byers, T. L. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1544541 · Cited by 242
Wild-type and mutated IDH1/2 enzymes and therapy responses
Molenaar, R. J., Maciejewski, J. P., Wilmink, J. W., & van Noorden, C. J. F. (2018) · Oncogene · doi:10.1038/s41388-017-0077-z · Cited by 241
Yang, Y.-P., Chien, Y., Chiou, G.-Y., Cherng, J.-Y., Wang, M.-L., Lo, W.-L., Chang, Y.-L., Huang, P.-I., Chen, Y.-W., Shih, Y.-H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.071 · Cited by 240
Ujifuku, K., Mitsutake, N., Takakura, S., Matsuse, M., Saenko, V., Suzuki, K., Hayashi, K., Matsuo, T., Kamada, K., Nagata, I., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.013 · Cited by 228
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0211-8 · Cited by 227
Fan, C.-H., Liu, W.-L., Cao, H., Wen, C., Chen, L., & Jiang, G. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.388 · Cited by 226
Baker, S. D., Wirth, M., Statkevich, P., Reidenberg, P., Alton, K. B., Sartorius, S. E., Dugan, M. H., Cutler, D. L., Batra, V. K., Grochow, L. B., et al. (1999) · PubMed · Cited by 221
Ronson, G. E., Piberger, A. L., Higgs, M. R., Olsen, A. L., Stewart, G. S., McHugh, P. J., Petermann, E., & Lakin, N. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03159-2 · Cited by 221
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
de Botton, S., Mondesir, J., Willekens, C., & Touat, M. (2016) · Journal of Blood Medicine · doi:10.2147/jbm.s70716 · Cited by 220
Li, H., Chen, L., Li, J.-J., Zhou, Q., Huang, A., Liu, W.-W., Wang, K., Gao, L., Qi, S.-T., & Lu, Y.-T. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0618-0 · Cited by 215
Temozolomide-associated hypermutation in gliomas
Choi, S., Yu, Y., Grimmer, M. R., Wahl, M., Chang, S. M., & Costello, J. F. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy016 · Cited by 214
A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
Srinivasan, S., Patric, I. R. P., & Somasundaram, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017438 · Cited by 207
Ulasov, I. V., Nandi, S., Dey, M., Sonabend, A. M., & Lesniak, M. S. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00062 · Cited by 204
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Oldrini, B., Vaquero-Siguero, N., Mu, Q., Kroon, P., Zhang, Y., Galán-Ganga, M., Bao, Z., Wang, Z., Liu, H., Sa, J. K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17717-0 · Cited by 203
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
Yin, J., Zeng, A., Zhang, Z., Shi, Z., Yan, W., & You, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.016 · Cited by 201
Perazzoli, G., Prados, J., Ortiz, R., Caba, O., Cabeza, L., Berdasco, M., Gónzalez, B., & Melguizo, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140131 · Cited by 198
Donson, A. M., Addo‐Yobo, S. O., Handler, M. H., Gore, L., & Foreman, N. K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20803 · Cited by 196
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Tchoghandjian, A., Baeza, N., Colin, C., Cayre, M., Metellus, P., Beclin, C., Ouafik, L., & Figarella‐Branger, D. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00269.x · Cited by 193
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
Chamberlain, M. C. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.32 · Cited by 188
Wang, J., Xu, S.-L., Duan, J.-J., Yi, L., Guo, Y.-F., Shi, Y., Li, L., Yang, Z.-Y., Liao, X.-M., Cai, J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0285-z · Cited by 180
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy
Golden, E. B., Cho, H.-Y., Jahanian, A., Hofman, F. M., Louie, S. G., Schönthal, A. H., & Chen, T. C. (2014) · Neurosurgical Focus · doi:10.3171/2014.9.focus14504 · Cited by 179
Agnihotri, S., Gajadhar, A. S., Ternamian, C., Gorlia, T., Diefes, K. L., Mischel, P. S., Kelly, J., McGown, G., Thorncroft, M., Carlson, B. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59334 · Cited by 172
Cheng, C. L., Johnson, S. P., Keir, S. T., Quinn, J. A., Ali-Osman, F., Szabo, C., Li, H., Salzman, A. L., Dolan, M. E., Modrich, P., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0128 · Cited by 171
MicroRNA in Glioblastoma: An Overview
Banelli, B., Forlani, A., Allemanni, G., Morabito, A., Pistillo, M. P., & Romani, M. (2017) · International Journal of Genomics · doi:10.1155/2017/7639084 · Cited by 168
Oct4 is expressed in human gliomas and promotes colony formation in glioma cells
Du, Z., Jia, D., Liu, S., Wang, F., Li, G., Zhang, Y., Cao, X., Ling, E., & Hao, A. (2009) · Glia · doi:10.1002/glia.20800 · Cited by 165
Yi, G.-Z., Huang, G., Guo, M., Zhang, X., Wang, H., Deng, S., Li, Y., Xiang, W., Chen, Z., Pan, J., et al. (2019) · Brain · doi:10.1093/brain/awz202 · Cited by 165
Comincini, S., Allavena, G., Palumbo, S., Morini, M., Durando, F., Angeletti, F., Pirtoli, L., & Miracco, C. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24597 · Cited by 163
Silber, J. R., Bobola, M. S., Blank, A., Schoeler, K. D., Haroldson, P. D., Huynh, M. B., & Kolstoe, D. D. (2002) · PubMed · Cited by 163
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
Yang, P., Zhang, W., Wang, Y., Peng, X., Chen, B., Qiu, X., Li, G., Li, S., Wu, C., Yao, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5683 · Cited by 162
Goellner, E. M., Grimme, B., Brown, A. R., Lin, Y., Wang, X., Sugrue, K. F., Mitchell, L., Trivedi, R. N., Tang, J.-B., & Sobol, R. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3213 · Cited by 161
Asuthkar, S., Velpula, K. K., Chetty, C., Gorantla, B., & Rao, J. S. (2012) · Oncotarget · doi:10.18632/oncotarget.683 · Cited by 153
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Garros-Regulez, L., Aldaz, P., Arrizabalaga, O., Moncho-Amor, V., Carrasco‐García, E., Manterola, L., Moreno‐Cugnon, L., Barrena, C., Villanúa, J., Ruiz, I., et al. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151002 · Cited by 151
Gap junctions modulate glioma invasion by direct transfer of microRNA
Hong, X., Sin, W. C., Harris, A. L., & Naus, C. C. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3904 · Cited by 146
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
Shu, M., Zheng, X., Wu, S., Lu, H., Leng, T., Zhu, W., Zhou, Y., Ou, Y., Lin, X., Lin, Y., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-59 · Cited by 139
O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy
Verbeek, B., Southgate, T. D., Gilham, D. E., & Margison, G. P. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldm036 · Cited by 138
Jaksch, M., Múnera, J. O., Bajpai, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0723 · Cited by 137
Shi, L. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1179 · Cited by 135
Vengoji, R., Macha, M. A., Nimmakayala, R. K., Rachagani, S., Siddiqui, J. A., Mallya, K. B., Gorantla, S., Jain, M., Ponnusamy, M. P., Batra, S. K., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1264-2 · Cited by 134
McFaline‐Figueroa, J. L., Braun, C. J., Stanciu, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3616 · Cited by 131
The emerging roles of Oct4 in tumor-initiating cells
Wang, Y., & Herlyn, M. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00212.2015 · Cited by 129
Tang, J.-B., Svilar, D., Trivedi, R. N., Wang, X., Goellner, E. M., Moore, B., Hamilton, R. L., Banze, L. A., Brown, A. R., & Sobol, R. W. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor011 · Cited by 127
Yoshimoto, K., Mizoguchi, M., Hata, N., Murata, H., Hatae, R., Amano, T., Nakamizo, A., & Sasaki, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00186 · Cited by 126
O6-Methylguanine-DNA methyltransferase in glioma therapy: Promise and problems
Silber, J. R., Bobola, M. S., Blank, A., & Chamberlain, M. C. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.004 · Cited by 125
Lee, S. W., Kim, H.-K., Lee, N. H., Yi, H.-Y., Kim, H.-S., Hong, S. H., Hong, Y.-K., & Joe, Y. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.012 · Cited by 123
Higuchi, F., Nagashima, H., Ning, J., Koerner, M. V. A., Wakimoto, H., & Cahill, D. P. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2000 · Cited by 122
ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
Han, B., Meng, X., Wu, P., Li, Z., Li, S., Zhang, Y., Zha, C., Ye, Q., Jiang, C., Cai, J., et al. (2020) · Theranostics · doi:10.7150/thno.41219 · Cited by 122
Yun, E.-J., Kim, S., Hsieh, J., & Baek, S. T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02988-8 · Cited by 121
Costello, J., Futscher, B. W., Kroes, R. A., & Pieper, R. O. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6515 · Cited by 117
Wong, T., Zhang, X., Zhuang, J. T.-F., Chan, H.-L., Li, C.-H., & Leung, G. (2012) · PubMed · Cited by 116
Håvik, A. B., Brandal, P., Honne, H., Dahlback, H. S., Scheie, D., Hektoen, M., Meling, T. R., Helseth, E., Heim, S., Lothe, R. A., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-36 · Cited by 114
Shah, N., Lin, B., Sibenaller, Z. A., Ryken, T. C., Lee, H., Yoon, J., Rostad, S. W., & Foltz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016146 · Cited by 112
Zhang, X. (2012) · Oncology Reports · doi:10.3892/or.2012.1715 · Cited by 108
Wang, P., Wan, W., Xiong, S., Feng, H., & Wu, N. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.105 · Cited by 108
Huang, W., Zhong, Z., Luo, C., Xiao, Y., Li, L., Zhang, X., Yang, L., Xiao, K., Ning, Y., Chen, L., et al. (2019) · Theranostics · doi:10.7150/thno.33800 · Cited by 108
Roos, W. P., Nikolova, T., Quirós, S., Naumann, S. C., Kiedron, O., Zdzienicka, M. Z., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.003 · Cited by 106
Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies
Ahmed, A. U., Auffinger, B., & Lesniak, M. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.42 · Cited by 103
Minniti, G. C., Salvati, M., Arcella, A., Buttarelli, F. R., D’Elia, A., Lanzetta, G., Esposito, V., Scarpino, S., Enrici, R. M., & Giangaspero, F. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0324-4 · Cited by 101
Radiation Resistance in Glioma Cells Determined by DNA Damage Repair Activity of Ape1/Ref-1
Naidu, M. D., Mason, J. M., PICA, R. V., Fung, H., & Peña, L. A. (2010) · Journal of Radiation Research · doi:10.1269/jrr.09077 · Cited by 99
Tentori, L., Ricci‐Vitiani, L., Muzi, A., Ciccarone, F., Pelacchi, F., Calabrese, R., Runci, D., Pallini, R., Caiafa, P., & Graziani, G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-151 · Cited by 98
Munoz, J. L., Rodriguez‐Cruz, V., Ramkissoon, S. H., Ligon, K. L., Greco, S. J., & Rameshwar, P. (2015) · Oncotarget · doi:10.18632/oncotarget.2778 · Cited by 98
Kitange, G. J., Carlson, B. L., Mladek, A. C., Decker, P. A., Schroeder, M. A., Wu, W., Grogan, P. T., Giannini, C., Ballman, K. V., Buckner, J. C., et al. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9737-8 · Cited by 97
Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery
Lystad, A. H., & Simonsen, A. (2019) · Cells · doi:10.3390/cells8090973 · Cited by 97
Hori, Y. S., Hosoda, R., Akiyama, Y., Sebori, R., Wanibuchi, M., Mikami, T., Sugino, T., Suzuki, K., Maruyama, M., Tsukamoto, M., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1686-9 · Cited by 96
Jiang, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1535 · Cited by 96
Melguizo, C., Prados, J. C., González, B., Ortíz, R., Concha, Á., Alvarez, P. J., Madeddu, R., Perazzoli, G., Oliver, J. A., López, R., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-250 · Cited by 95
Shen, C., Oswald, D. J., Phelps, D. A., Çam, H., Pelloski, C. E., Pang, Q., & Houghton, P. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4282 · Cited by 92
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
Regazzo, G., Terrenato, I., Spagnuolo, M., Carosi, M., Cognetti, G., Cicchillitti, L., Sperati, F., Villani, V., Carapella, C. M., Piaggio, G., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0393-0 · Cited by 92
Fang, C.-B., Wu, H.-T., Zhang, M., Liu, J., & Zhang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00160 · Cited by 91
Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma
Zou, Y., Wang, Q., Li, B., Xie, B., & Wang, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2151 · Cited by 88
MicroRNAs and glioblastoma; the stem cell connection
Godlewski, J., Newton, H. B., Chiocca, E. A., & Lawler, S. E. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.71 · Cited by 86
Valtorta, S., Dico, A. L., Raccagni, I., Gaglio, D., Belloli, S., Politi, L. S., Martelli, C., Diceglie, C., Bonanomi, M., Ercoli, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23028 · Cited by 86
Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
Qiu, Z.-K., Shen, D., Chen, Y.-S., Yang, Q.-Y., Guo, C.-C., Feng, B.-H., & Chen, Z. P. (2013) · 癌症:英文版 · doi:10.5732/cjc.012.10236 · Cited by 84
Kanzawa, T., Germano, I. M., Kondo, Y., Ito, H., Kyo, S., & Kondo, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601193 · Cited by 83
Tang, H., Bian, Y., Tu, C., Wang, Z., Yu, Z., Liu, Q., Xu, G., Wu, M., & Li, G. (2013) · Current Cancer Drug Targets · doi:10.2174/1568009611313020010 · Cited by 83
Chang, K., Hsu, T., Hsu, C.-C., Tsai, S.-Y., Liu, J.-J., Chou, S.-W., Liu, M.-S., Liou, J., Ko, C., Chen, K., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.005 · Cited by 82
Shinsato, Y., Furukawa, T., Yunoue, S., Yonezawa, H., Minami, K., Nishizawa, Y., Ikeda, R., Kawahara, K., Yamamoto, M., Hirano, H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1302 · Cited by 81
Zhang, S., Wan, Y., Pan, T., Gu, X., Qian, C., Sun, G., Sun, L., Xiang, Y., Wang, Z., & Shi, L. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9759-8 · Cited by 76
Montaldi, A. P., Godoy, P. R. D. V., & Sakamoto‐Hojo, E. T. (2015) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2015.06.001 · Cited by 75
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas
Kushwaha, D. S., Ramakrishnan, V., Ng, K., Steed, T., Nguyen, T. P., Futalan, D., Akers, J. C., Sarkaria, J. N., Jiang, T., Chowdhury, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1974 · Cited by 75
Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines
Mohammed, M., Vyjayanti, V. N., Laughton, C. A., Dekker, L. V., Fischer, P. M., Wilson, D. M., Abbotts, R., Shah, S., Patel, P. M., Hickson, I. D., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606058 · Cited by 72
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
Chen, Y., Meng, D., Wang, H., Sun, R., Wang, D., Wang, S., Fan, J., Zhao, Y., Wang, J., Yang, S. T., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou219 · Cited by 69
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
Liu, Y., Lang, F., Chou, F.-J., Zaghloul, K. A., & Yang, C. (2020) · Biomedicines · doi:10.3390/biomedicines8090294 · Cited by 67
Yu, Z., Chen, Y., Wang, S., Li, P., Zhou, G., & Yuan, Y. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.033 · Cited by 65
Criscuolo, D., Morra, F., Giannella, R., Visconti, R., Cerrato, A., & Celetti, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1089-z · Cited by 65
Suwala, A. K., Koch, K., Herrera-Rios, D., Aretz, P., Uhlmann, C., Ogorek, I., Felsberg, J., Reifenberger, G., Köhrer, K., Deenen, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25210 · Cited by 63
Šáňa, J., Lakomý, R., Hajdúch, M., & Slabý, O. (2012) · Cited by 58
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
Hiddingh, L., Tannous, B. A., Teng, J., Tops, B. B. J., Jeuken, J. W. M., Hulleman, E., Boots‐Sprenger, S., Vandertop, W. P., Noske, D. P., Kaspers, G. J. L., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1620 · Cited by 57
Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
Scicchitano, B. M., Sorrentino, S., Proietti, G., Lama, G., Dobrowolny, G., Catizone, A., Binda, E., Larocca, L. M., & Sica, G. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0626-8 · Cited by 57
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
Tian, T., Mingyi, M., Qiu, X., & Qiu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12861 · Cited by 56
Current views on the source of the autophagosome membrane
Tooze, S. A. (2013) · Essays in Biochemistry · doi:10.1042/bse0550029 · Cited by 54
Stritzelberger, J., Distel, L. V., Buslei, R., Fietkau, R., & Putz, F. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1743-x · Cited by 53
Bi, Y., Han, L., Yi, D., Sun, Y., Bai, Y., Zhong, S., Song, Y., Zhao, G., & Chen, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00551 · Cited by 53
Gupta, V. K., Su, Y. S., Wang, W., Kardosh, A., Liebes, L., Hofman, F. M., Schönthal, A. H., & Chen, T. C. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.4.13 · Cited by 52
Hudson, A. L., Parker, N., Khong, P., Parkinson, J., Dwight, T., Ikin, R. J., Zhu, Y., Chen, J., Wheeler, H., & Howell, V. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00314 · Cited by 52
Bi, Y., Han, L., Yi, D., Bai, Y., Zhong, S., Liu, Q., Chen, Y., & Zhao, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.040 · Cited by 52
Guerra‐Rebollo, M., Garrido, C., Sánchez‐Cid, L., Soler‐Botija, C., Meca‐Cortés, Ó., Rubio, N., & Blanco, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-46014-0 · Cited by 52
Yang, W., Chuang, J., Ko, C., Chang, W., & Hsu, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1221-7 · Cited by 51
Glioblastoma Recurrence and the Role of O6-Methylguanine–DNA Methyltransferase Promoter Methylation
Storey, K. M., Leder, K., Hawkins-Daarud, A. J., Swanson, K. R., Ahmed, A. U., Rockne, R. C., & Foo, J. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00062 · Cited by 51
Zhao, C., Guo, R., Guan, F., Ma, S., Li, M., Wu, J., Liu, X., Li, H., & Yang, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65331-3 · Cited by 51
Association between IDH1/2 mutations and brain glioma grade
Deng, L., Xiong, P., Luo, Y., Bu, X., Qian, S., Zhong, W., & Lv, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9317 · Cited by 50
Poon, W. S., Woo, P. M., Li, Y., Chan, A. Y., Ng, S. P., Loong, H. H.-F., Chan, D. M., & Wong, G. K. C. (2019) · Glioma · doi:10.4103/glioma.glioma_3_19 · Cited by 50
Auvergne, R. M., Wu, C., Connell, A., Au, S., Cornwell, A., Osipovitch, M., Benraiss, A., Dangelmajer, S., Guerrero‐Cazares, H., Quiñones-Hinojosa, A., et al. (2015) · Oncogene · doi:10.1038/onc.2015.452 · Cited by 49
Zhang, X., Liu, X., Zhou, W., Yang, M., Ding, Y., Wang, Q., & Hu, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0251-9 · Cited by 49
Glioblastoma stem cells and Wnt signaling pathway: molecular mechanisms and therapeutic targets
Guan, R., Zhang, X., & Guo, M. (2020) · Chinese Neurosurgical Journal · doi:10.1186/s41016-020-00207-z · Cited by 49
Wang, J., Dong, D.-F., Wang, M., & Gao, K. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.427 · Cited by 48
Yang, Z., Wei, D., Dai, X., Stevens, M. F. G., Bradshaw, T. D., Luo, Y., & Zhang, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00485 · Cited by 46
Patil, A. A., Sayal, P. P., Depondt, M.-L., Beveridge, R. D. D., Roylance, A., Kriplani, D. H., Myers, K. N., Cox, A., Jellinek, D. A., Fernando, M. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2225 · Cited by 45
Yihan, W., Li, D., Bao, S., Wang, M., Yun, Y.-L., & Zhu, R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.051 · Cited by 45
Salaroglio, I. C., Mujumdar, P., Annovazzi, L., Kopecka, J., Mellai, M., Schiffer, D., Poulsen, S., & Riganti, C. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0533 · Cited by 45
Tsai, C., Huang, L., Wu, Y., Kan, I., & Hueng, D. (2019) · The FASEB Journal · doi:10.1096/fj.201901021rr · Cited by 45
Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma
Kwon, J., Lee, T. S., Lee, H. W., Kang, M. C., Yoon, H.-J., KIM, J.-H., & Park, J. H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2097 · Cited by 44
FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ
Kondo, N., Takahashi, A., Mori, E., Noda, T., Zdzienicka, M. Z., Thompson, L. H., Helleday, T., Suzuki, M., Kinashi, Y., Masunaga, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019659 · Cited by 43
Zhang, P., Chen, X., Ding, B., Liu, H., & He, T. (2018) · Bioscience Reports · doi:10.1042/bsr20181711 · Cited by 43
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells
Zhu, Z., Zhang, P., Li, N., Kiang, K. M. Y., Cheng, S. Y., Wong, V. K. W., & Leung, G. (2019) · BioMed Research International · doi:10.1155/2019/2710693 · Cited by 43
Forte, I. M., Indovina, P., Iannuzzi, C. A., Cirillo, D., Marzo, D. D., Barone, D., Capone, F., Pentimalli, F., & Giordano, A. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4788 · Cited by 43
Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
Zhi-Kun, Qiu, Dong, et al. (2014) · 癌症:英文版 · Cited by 43
Tsai, C.-Y., Ko, H.-J., Chiou, S.-J., Lai, Y.-L., Hou, C.-C., Javaria, T., Huang, Z.-Y., Cheng, T.-S., Hsu, T., Chuang, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115907 · Cited by 43
Li, P., Lu, X., Wang, Y., Sun, L., Qian, C., Yan, W., Liu, N., You, Y., & Fu, Z. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60058-9 · Cited by 41
Ciechomska, I. A., Marciniak, M. P., Jackl, J., & Kaminska, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01271 · Cited by 41
SOX3 can promote the malignant behavior of glioblastoma cells
Marjanović, J., Drakulić, D., García, I., Vuković, V., Aldaz, P., Puškaš, N., Nikolić, I., Tasić, G., Raičević, S., Garros-Regulez, L., et al. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0405-5 · Cited by 40
Balça-Silva, J., Matias, D., do Carmo, A., Girão, H., Moura‐Neto, V., Sarmento‐Ribeiro, A. B., & Lopes, M. C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.022 · Cited by 39
Carter, T. C., Medina‐Flores, R., & Lawler, B. (2018) · BioMed Research International · doi:10.1155/2018/6204676 · Cited by 39
Doan, P., Musa, A., Murugesan, A., Sipilä, V., Candeias, N. R., Emmert‐Streib, F., Ruusuvuori, P., Granberg, K. J., Yli-Harja, O. P., & Kandhavelu, M. (2020) · Cells · doi:10.3390/cells9030681 · Cited by 37
The impact of autophagy during the development and survival of glioblastoma
Simpson, J. E., & Gammoh, N. (2020) · Open Biology · doi:10.1098/rsob.200184 · Cited by 37
Kaur, S. J., Ramdzan, Z. M., Guiot, M., Li, L., Leduy, L., Ramotar, D., Sabri, S., Abdulkarim, B., & Nepveu, A. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox178 · Cited by 36
Gong, R., Li, Z., Fu, K., Ma, C., Wang, W. T., & Chen, J. (2021) · Experimental Neurobiology · doi:10.5607/en20060 · Cited by 36
MicroRNAs in Human Malignant Gliomas
Mizoguchi, M., Guan, Y., Yoshimoto, K., Hata, N., Amano, T., Nakamizo, A., & Sasaki, T. (2012) · Journal of Oncology · doi:10.1155/2012/732874 · Cited by 34
Balvers, R. K., Lamfers, M. L. M., Kloezeman, J. J., Kleijn, A., Pont, L. M. E. B., Dirven, C. M. F., & Leenstra, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0427-y · Cited by 34
Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
Ströbel, T., Madlener, S., Tuna, S., Vose, S. C., Lagerweij, T., Würdinger, T., Vierlinger, K., Wöehrer, A., Price, B. D., Demple, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10013-w · Cited by 34
Yu, X., Wang, M., Zuo, J., Wahafu, A., Mao, P., Li, R., Wu, W., Xie, W., & Wang, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116917 · Cited by 34
Metselaar, D. S., Meel, M. H., Benedict, B., Waranecki, P., Köster, J., Kaspers, G. J. L., & Hulleman, E. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.062 · Cited by 34
Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma
Sun, Q., Pei, C., Li, Q., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.093 · Cited by 32
Ramirez, Y. P., Mladek, A. C., Phillips, R. M., Gynther, M., Rautio, J., Ross, A. H., Wheelhouse, R. T., & Sakaria, J. N. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0113 · Cited by 27
LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
Liu, B., Guo, Z., Dong, H., Daofeng, T., Cai, Q., Ji, B., Zhang, S., Wu, L., Wang, J., Wang, L., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.023 · Cited by 24
Pandith, A. A., Qasim, I., Baba, S. M., Koul, A. M., Zahoor, W., Afroze, D., Lateef, A., Manzoor, U., Bhat, I. A., Sanadhya, D., et al. (2020) · Future Science OA · doi:10.2144/fsoa-2020-0057 · Cited by 21
Circulating miR-128 as a potential diagnostic biomarker for glioma
Liang, R., Mao, L., Yang, Y., Wang, X., Mao, Q., & Liu, Y. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.06.020 · Cited by 20
Yang, B., Ma, Y., & Chu, S. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0040-3 · Cited by 18
Taipakova, S., Kuanbay, A. K., Saint‐Pierre, C., Gasparutto, D., Baiken, Y., Groisman, R., Ishchenko, A. A., Saparbaev, M. K., & Bissenbaev, A. K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.606596 · Cited by 17
McDonald, K. L., Tabone, T., Nowak, A. K., & Erber, W. N. (2015) · Oncology Letters · doi:10.3892/ol.2015.2980 · Cited by 16
Wu, Q., Berglund, A., Wang, D., Macaulay, R. J. B., Mulé, J. J., & Etame, A. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-50489-2 · Cited by 16
Tooyama, I., Yamada, T., Kim, S. U., & McGeer, P. L. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90655-q · Cited by 15
The role of octamer binding transcription factors in glioblastoma multiforme
Rooj, A. K., Bronisz, A., & Godlewski, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.003 · Cited by 15
Jurić, V., Düßmann, H., Lamfers, M. L. M., et al. (2021) · Cells · doi:10.3390/cells10051182 · Cited by 12
Guo, J., Yi, G., Liu, Z., Sun, X., Yang, R., Guo, M., Li, Y., Li, K., Li, K., Wang, X., et al. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3459 · Cited by 11
Ohnishi, K., Tani, T., Tojo, N., & Sagara, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.009 · Cited by 9
Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer
Guo, F. (2014) · Journal of Oncobiomarkers · doi:10.13188/2325-2340.1000008 · Cited by 6
Barange, M., Epari, S., Gurav, M., Shetty, O. A., Sahay, A., Shetty, P. M., Goda, J., Moyiadi, A., Gupta, T., & Jalali, R. (2021) · Neurology India · doi:10.4103/0028-3886.310096 · Cited by 4
Correction: FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ
Kondo, N., Takahashi, A., Mori, E., Noda, T., Zdzienicka, M. Z., Thompson, L. H., Helleday, T., Suzuki, M., Kinashi, Y., Masunaga, S., et al. (2011) · PLoS ONE · doi:10.1371/annotation/c6be24d1-bc23-43b4-ae01-b86dad174069 · Cited by 3
Cited by
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
Metadata
- Authors
- Tomar, M. S., Kumar, A., Srivastava, C., & Shrivastava, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 1876
- Issue
- 2
- Pages
- 188616
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W3195630950
- Cited by
- 325
- References
- 200
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.